Literature DB >> 9627146

Low molecular weight heparin-induced skin necrosis occurring distant from injection sites and without thrombocytopenia.

U J Tietge1, H H Schmidt, E Jäckel, C Trautwein, M P Manns.   

Abstract

In this paper we report a case of 76-year-old white male patient with skin necrosis induced by subcutaneous prophylactic administration of low-molecular-weight heparin (LMWH). Skin necrosis occurred distant from heparin injection sites and without concomitant thrombocytopenia. This is the first reported case presenting these clinical findings.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627146     DOI: 10.1046/j.1365-2796.1998.00304.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

1.  [Cutaneous necroses mainly on the extremities].

Authors:  W K Peitsch; E Glorer; C-E Dempfle; W Back; C Bayerl; S Goerdt
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

2.  Nadroparin-induced skin necrosis: clinical manifestation of HIT-2 even in the absence of thrombocytopaenia.

Authors:  Diego Luis Carrillo Pérez; Adriana Guadalupe Peña-Romero; José Manuel Díaz-González; Judith Domínguez-Cherit
Journal:  BMJ Case Rep       Date:  2016-04-26

3.  [Dermal necrosis as cutaneous manifestation of heparin-induced thrombocytopenia II?].

Authors:  M Illes; S Klaus; J C Simon; R Treudler
Journal:  Hautarzt       Date:  2011-04       Impact factor: 0.751

Review 4.  Low molecular weight heparin-induced skin necrosis-a systematic review.

Authors:  A E Handschin; O Trentz; H J Kock; G A Wanner
Journal:  Langenbecks Arch Surg       Date:  2004-11-27       Impact factor: 3.445

5.  Nadroparine-induced skin necrosis on a patient with essential thrombocythaemia: a case report.

Authors:  Manousos-Georgios Pramateftakis; Dimitrios Kanellos; Stefanos Psomas; Ioannis Kanellos
Journal:  Cases J       Date:  2009-03-10

Review 6.  Cutaneous Drug Reactions in the Elderly.

Authors:  James W S Young; Neil H Shear
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 4.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.